MENU
+Compare
FBT
ETF ticker: NYSE ARCA
AS OF
Apr 3, 01:17 PM (EDT)
Price
$163.18
Change
-$2.81 (-1.69%)
Net Assets
1.08B

FBT stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index... Show more

Category: #Health
FBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for FBT with price predictions
Apr 02, 2025

FBT in downward trend: price dove below 50-day moving average on March 06, 2025

FBT moved below its 50-day moving average on March 06, 2025 date and that indicates a change from an upward trend to a downward trend. In of 47 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FBT as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for FBT turned negative on April 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for FBT crossed bearishly below the 50-day moving average on March 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FBT entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FBT's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where FBT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FBT advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .

FBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.

Market Cap

The average market capitalization across the First Trust NYSE Arca Biotech ETF ETF is 27.21B. The market cap for tickers in the group ranges from 1.62B to 151.69B. AMGN holds the highest valuation in this group at 151.69B. The lowest valued company is DVAX at 1.62B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was 45%. For the same ETF, the average monthly price growth was 46%, and the average quarterly price growth was 81%. CORT experienced the highest price growth at 47%, while PTCT experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was 53%. For the same stocks of the ETF, the average monthly volume growth was 10% and the average quarterly volume growth was 101%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 71
P/E Growth Rating: 61
Price Growth Rating: 56
SMR Rating: 66
Profit Risk Rating: 54
Seasonality Score: -9 (-100 ... +100)
View a ticker or compare two or three
FBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
First Trust Exchange-Traded Fund1001 Warrenville Road, Suite 300Lisle
Phone
630-241-4141
Web
www.ftportfolios.com